Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide

Author： Wang Xiang Chen Jin-xiu Liu Jin-ping You Chao Liu Yan-hui Mao Qing

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.21, Iss.4, 2014-04, pp. : 1337-1344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

By Rahko E. Blanco G. Soini Y. Bloigu R. Jukkola A.

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 447-453

Elsevier

Access to resources Recommend Favorite

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma

By Blough Michael Beauchamp Desiree Westgate Morgan Kelly John Cairncross J.

Journal of Neuro-Oncology, Vol. 102, Iss. 1, 2011-03 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

Relationship between cognitive function and prognosis in glioblastoma

By Johnson Derek R Wefel Jeffrey S

CNS Oncology, Vol. 2, Iss. 2, 2013-03 ,pp. : 195-201

Future Medicine

Access to resources Recommend Favorite

TP53 Mutations and Abnormal p53 Protein Staining in Breast Carcinomas Related to Prognosis

By Thorlacius S. Thorgilsson B. Bjornsson J. Tryggvadottir L. Borresen A.-L. Ogmundsdottir H.M. Eyfjord J.E.

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1856-1861

Elsevier

Access to resources Recommend Favorite

Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1465-1474

Spandidos Publications

Access to resources Recommend Favorite